Epidemiology of Chronic and Communicable Diseases

Group co-leader: Pilar Amiano Etxezarreta

Dep. Health – Subdirection PH Gipuzkoa E-mail p-amiano@euskadi.eus

Group co-leader: Ana María Jiménez Zabala, Ph.D.

Dep. Health – Subdirection PH Gipuzkoa E-mail am-jimenez@euskadi.eus
Ms. Pilar Amiano Etxezarreta has a Degree in Pharmacy from the University of Santiago de Compostela; Master’s Degree in Public Health and Environment, Free University of Brussels. Since 2019, she has been co-leader of the Epidemiology of Chronic and Communicable Diseases Group at the Biogipuzkoa HRI, in turn belonging to the Basque Government Sub-Office of Public Health and Addictions. She is specialized in  Nutritional Epidemiology and Brest Epidemiology. She is the Principal Researcher in Gipuzkoa of the European EPIC Project: European Prospective Investigation of Cancer and of the MCC-Spain study, Multicase-control. He is part of the research team of INMA Environment and Childhood project. She has more than 300 publications in high-impact journals.
She belongs to the Epidemiology Unit of the Gipuzkoa Sub-Office of Public Health and Addictions, where he collaborates in the management of outbreaks within the community and interpreting results for the purposes of handling cases.
Ana M. Jiménez Zabala is a PhD in Biological Sciences from the University of Navarre. She has carried out all her professional activity in the Department of Health of the Basque Government and since 2018, she has been Head of Public Health Programmes in the Sub-Directorate of Public Health and Addictions of Gipuzkoa, where she performs functions related to the monitoring and control of environmental risks and food consumption. In the field of research, he has collaborated with different research groups in the EPIC-España (European Prospective Investigation of Cancer), INMA (Childhood and Environment) and MCC-Spain (Multi-Control Case) projects. Since 2024, she has been co-leader of the Epidemiology of Chronic and Communicable Diseases group of the Research Area of Epidemiology and Public Health research area of the Biogipuzkoa HRI.

 Communication to the participants of the EPIC-Gipuzkoa study – CORDELIA Project (Spanish version)

Strategic Objectives

  • To generate scientific knowledge that is directly relevant to controlling chronic diseases, which are the main causes of loss of health and the use of Health Services in Spain; also to generate scientific knowledge about these communicable diseases that can act as a base on which to support the actions carried out by the Health Authorities.
  • To promote cooperative research among different groups, encouraging collaboration between researchers and boosting the internationalisation of their activities, and to develop strategies to improve the researchers’ scientific capacities.
  • To assess the effectiveness and efficiency of the interventions carried out with a Public Health services perspective.
  • To foster the transfer of knowledge to the Health Service to help design and implement health policies.

Specific Objectives

Epidemiology and surveillance of communicable diseases:

  • Survey of seroprevalence in the Autonomous Community of the Basque Country.
  • Study of the effectiveness of the flu vaccine (cycEVA).
  • Tuberculosis and social inequality in Gipuzkoa in the period 2003-2009.
  • Study of the high incidence of cases of sporadic Creutzfeldt-Jakob disease in the Autonomous Community of the Basque Country.

Epidemiology and control of chronic diseases:

  • Strategy integrated into the municipal health area to promote physical exercise in fragile elderly people. Tipi-tapa.
  • Study of the distribution of COPD and asthma in Gipuzkoa.
  • Escape (European Study of Cohorts for Air Pollution Effects).
  • Assessment of the equity, variability and results between centres and Autonomous Communities in Spain.
  • Preparation of cancer profiles in different regions.
  • Socio-economic inequalities in the risk of cancer.
  • Assessment of the health and cost benefits at a population level of the early breast cancer detection programme in the Autonomous Community of the Basque Country.
  • MCC-SPAIN Population multi-case control study, including tumours with a high incidence in Spain.
  • Contaminants and cancer: biomarkers of exposure, genetic susceptibility and early damage markers.
  • Epidemiology of cardiovascular diseases. Linked with the EPIC-Heart and EPIC-CVD projects. Study of the association between alcohol consumption, meat/protein consumption, fish/omega-3 consumption and stroke in the Spanish cohort of the EPIC study.
  • Surveillance of accidents in people over the age of 64 and resident in the Autonomous Community of the Basque Country through a lookout network.
  • Ageing and neurodegenerative diseases.
  • Social networks for elderly people: identification, characterisation and analysis of their relationship with lifestyle habits related to health.

Nutritional epidemiology:

  • Alcohol consumption and genetic susceptibility: Case-control study.
  • Development of EPic-soft: diet assessment methodology.

Main lines of research

  • Epidemiology and surveillance of infectious and communicable diseases:
    • Flu.
    • Vaccine-preventable diseases caused by viruses (measles, rubella and mumps) or bacteria (whooping cough, pneumococcal disease or meningococcal disease).
    • Epidemic outbreaks
    • Tuberculosis.
  • Epidemiology and Control of Chronic Diseases:
    • Environmental and genetic determining factors of cancer, cardiovascular diseases and diabetes.
    • Other chronic disorders of high social impact.
    • Eating habits and their effect on health.
    • Epidemiology and prevention of accidental injuries.
    • Assessment of quality of care and quality of life.
    • Inequalities in health according to social class, gender, geographical location and environment.
    • Epidemiology of neurodegenerative diseases. Parkinson’s Disease and Alzheimer’s Disease and other cognitive disorders.
    • Genetic-environmental interaction in chronic diseases.
  • Nutritional epidemiology:
    • Diet and chronic diseases: cancer, cardiovascular or diabetes.
    • Research in methodology to assess diet: new instruments.
    • Assessment of diet in epidemiological case-control studies and cohorts.

Team Members

Name Surname Center E-mail
Eunate Abilleira Cillero Dep. Health – Subdirection PH Gipuzkoa
Adrián Aguinagalde Llorente Dep. Health – Subdirection PH Gipuzkoa ah-llorente@euskadi.eus
Amaia Aizpurua Atxega Dep. Health – Subdirection PH Gipuzkoa a-aizpuruaatxega@euskadi.eus
Ane Dorronsoro Erauskin Dep. Health – Subdirection PH Gipuzkoa a-dorronsoroerauskin@euskadi.eus
Leire Gil Majuelo Dep. Health – Subdirection PH Gipuzkoa l-gil@euskadi.eus
Liher Imaz Goienetxea Dep. Health – Subdirection PH Gipuzkoa l-imazgoienetxea@euskadi.eus
Arantza López de Munain Marqués Dep. Health – Subdirection PH Gipuzkoa
Olatz Mokoroa Carollo Dep. Health – Subdirection PH Gipuzkoa o-mokoroa@euskadi.eus
Rosa María Sancho Martínez Dep. Health – Subdirection PH Gipuzkoa r-sanchomartinez@euskadi.eus
Cristina Sarasqueta Eizaguirre Donostialdea IHO cristina.sarasquetaeizaguirre@osakidetza.eus

 

Scientific Output

ALLOSTATIC LOAD, ENVIRONMENTAL FACTORS, AND COLORECTAL CANCER IN THE EUROPEAN PROSPECTIVE INVESTIGATION INTO CANCER AND NUTRITION (EPIC)-SPAIN COHORT
Código: CIBERESP/INTRAMURAL/2023/001
Investigador Principal (IP): PILAR AMIANO ETXEZARRETA
Entidad Financiadora: CIBER DE EPIDEMIOLOGIA Y SALUD PUBLICA
Fecha de Inicio: 2024-01-01
Fecha de finalización: 2025-12-31
Importe Concedido: 8.265,00 €
EL PRIMER ESTUDIO DE ASOCIACION DE GENOMA COMPLETO (GWAS) CON ENFERMEDAD CORONARIA POBLACIONAL A 10 AÑOS EN MAS DE 100.000 PARTICIPANTES PARA PERSONALIZAR LA PREVENCION CARDIOVASCULAR EN ESPAÑA
Código: PMP22/00033
Investigador Principal (IP): PILAR AMIANO ETXEZARRETA
Entidad Financiadora: ISCIII INSTITUTO DE SALUD CARLOS III
Fecha de Inicio: 2023-01-01
Fecha de finalización: 2025-12-31
Importe Concedido: 39.000,00 €
IMPACTO DE LA PANDEMIA POR COVID-19 EN LOS ESTILOS DE VIDA RELACIONADOS CON LA SALUD Y EN LA CALIDAD DE VIDA EN LA POBLACION MAYOR DE 60 AÑOS EN ESPAÑA
Código: PI21/01434
Investigador Principal (IP): PILAR AMIANO ETXEZARRETA
Entidad Financiadora: ISCIII INSTITUTO DE SALUD CARLOS III
Fecha de Inicio: 2022-01-01
Fecha de finalización: 2024-12-31
Importe Concedido: 86.515,00 €
FACTORES DE RIESGO DE RESULTADOS ADVERSOS EN EL SEGUIMIENTO A LARGO PLAZO DE UNA COHORTE PROSPECTIVA DE PACIENTES CON CÁNCER DE MAMA. ESTUDIO MULTICÉNTRICO CAMISS II
Código: 2019111042/BD
Investigador Principal (IP): CRISTINA SARASQUETA EIZAGUIRRE
Entidad Financiadora: DEPARTAMENTO DE SALUD
Fecha de Inicio: 2019-11-30
Fecha de finalización: 2025-04-21
Importe Concedido: 0,00 €
CIBERESP - EPIDEMOLOGIA Y SALUD PUBLICA
Código: CB06/02/0072
Investigador Principal (IP): MIREN DORRONSORO IRAETA; JESUS MARIA IBARLUZEA MAUROLAGOITIA
Entidad Financiadora: ISCIII INSTITUTO DE SALUD CARLOS III
Fecha de Inicio: 2011-03-31
Fecha de finalización: 2030-12-31
Importe Concedido: 0,00 €